Prof. Anders Åsberg, Norway
A limited sampling strategy to estimate whole blood and intra-lymphocyte exposure of everolimus in renal transplant recipients using population pharmacokinetic modeling and bayesian estimators

Dr. Mohan Patel, India
Prediction of tacrolimus drug dosing and metabolism based on CYP3A5 polymorphism in Indian renal transplant recipients

Dr. Nancy Perrottet, Switzerland
Acute antibody-mediated rejection and its treatment in kidney transplantation: Report from a national cohort study

Ms. Yuanfei Zhao, Australia
The suppressive function of the human regulatory macrophages in-vitro have more potency but not in-vivo

Dr. Yeqi Nian, United States
Tacrolimus exerts age-specific immunosuppressive effects linked to modifications of CD4+ T cells metabolism

Dr. Peter Bernhardt, Switzerland
Effects of the de novo use of everolimus with reduced calcineurin inhibitor on wound healing events in the TRANSFORM study